Want to see OSCR full AI Analyst Report?
OSCR Stock Chart & Stats
$30.93
$0.77(2.73%)
At close: 4:00 PM EDT
$30.93
$0.77(2.73%)
Day’s Range― - ―
52-Week Range$10.69 - $33.55
Previous CloseN/A
Volume8.39K
Average Volume (3M)5.26M
Market Cap
$9.55B
Enterprise Value$9.94K
Total Cash (Recent Filing)$8.56B
Total Debt (Recent Filing)$431.63M
Price to Earnings (P/E)18.3
Beta1.03
Next Earnings
Nov 10, 2026EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.71
Shares Outstanding273,469,000
10 Day Avg. Volume3,962,270
30 Day Avg. Volume5,255,678
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.86
Price to Sales (P/S)0.32
P/FCF Ratio3.56
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$30.57Price Target Upside-1.16% Downside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)1.66
Revenue Forecast (FY)$18.68B
Bulls Say, Bears Say
Bulls Say
Revenue And Membership GrowthRapid revenue and membership expansion is strengthening Oscar’s scale in ACA marketplaces. A larger enrollment base can improve fixed-cost absorption, broaden data advantages and support stronger negotiating and operating leverage over the next several quarters.
Medical Cost And SG&A EfficiencyImproving medical loss performance and sharply lower administrative costs indicate better pricing, care management and technology execution. If sustained, these gains can support more durable margins and reduce the expense burden as membership continues to scale.
Liquidity And Capital StrengthSubstantial liquidity and excess insurance capital provide resilience against claims volatility, regulatory requirements and enrollment investment. Combined with manageable leverage, this gives Oscar flexibility to fund growth while absorbing adverse healthcare-cost or risk-adjustment developments.
Bears Say
Inconsistent Profitability And Thin MarginsThe return to positive earnings is encouraging, but Oscar’s uneven history shows that profitability remains sensitive to medical costs, pricing and risk adjustment. Thin margins leave limited room for execution errors and make earnings durability less certain.
CMS Eligibility And Churn RiskPotential disenrollment of members identified through CMS reviews could reduce enrollment scale and disrupt revenue planning. It may also alter the risk mix of the remaining population, creating lasting uncertainty for pricing, retention and risk-adjustment outcomes.
Medical Utilization UncertaintyHigher outpatient use and seasonal medical-cost pressure could reverse part of the recent MLR improvement. Because favorable morbidity evidence is still based on limited claims data, Oscar has not yet demonstrated that the improved cost trend is durable across a full cycle.
Oscar Health News
OSCR FAQ
What was Oscar Health’s price range in the past 12 months?
Oscar Health lowest stock price was $10.69 and its highest was $33.55 in the past 12 months.
What is Oscar Health’s market cap?
Oscar Health’s market cap is $9.55B.
When is Oscar Health’s upcoming earnings report date?
Oscar Health’s upcoming earnings report date is Nov 10, 2026 which is in 75 days.
How were Oscar Health’s earnings last quarter?
Oscar Health released its earnings results on Aug 06, 2026. The company reported $1.1 earnings per share for the quarter, beating the consensus estimate of $0.403 by $0.697.
Is Oscar Health overvalued?
According to Wall Street analysts Oscar Health’s price is currently Overvalued.
Does Oscar Health pay dividends?
Oscar Health does not currently pay dividends.
What is Oscar Health’s EPS estimate?
Oscar Health’s EPS estimate is -0.22.
How many shares outstanding does Oscar Health have?
Oscar Health has 273,469,000 shares outstanding.
What happened to Oscar Health’s price movement after its last earnings report?
Oscar Health reported an EPS of $1.1 in its last earnings report, beating expectations of $0.403. Following the earnings report the stock price went down -11.857%.
Which hedge fund is a major shareholder of Oscar Health?
Currently, no hedge funds are holding shares in OSCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oscar Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$30.57 (-1.16% Downside)
$30.57 (-1.16% Downside)
Blogger Sentiment
Bullish
OSCR Sentiment 89%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $595.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
98.52%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
78.15%
Trailing 12-Months
Company Description
Oscar Health
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
OSCR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys materially positive operating momentum: very strong revenue growth, sizeable membership expansion, record-low SG&A, marked improvement in profitability metrics and a raised earnings outlook. Management also emphasized technology and AI-driven efficiency gains and favorable risk‑adjustment developments that underpin the improved guidance. Offsetting items include an ongoing industry-wide ACA market contraction, elevated outpatient utilization and medical PMPM seasonality, and near-term uncertainty from CMS eligibility/program-integrity actions and limited early-year morbidity data. On balance, the positive operational and financial drivers substantially outweigh the risks flagged for the back half of the year.View all OSCR earnings summariesOSCR Stock 12 Month Forecast
Average Price Target
$30.57
▼(-1.16% Downside)
Technical Analysis
Centene
―
Humana
―
Molina Healthcare
―
Clover Health Investments
―
Alignment Healthcare
―
Ownership Overview
4.40% Insiders
16.17% Mutual Funds
17.53% Other Institutional Investors
43.39% Public Companies and Individual Investors